Affordable cancer care: pipedream or achievable reality?

Affiliations

¹ The Lancet Oncology, 32 Jamestown Road, London NW1 7BY, UK. Electronic address: david.collingridge@lancet.com.
² Kings Health Partners, King's College, Guy's Hospital Campus, London SE1 9RT, UK.

Comment

David Collingridge et al. Lancet Oncol. 2014 Mar.

. 2014 Mar;15(3):257-8.

doi: 10.1016/S1470-2045(14)70062-2. Epub 2014 Feb 14.

¹ The Lancet Oncology, 32 Jamestown Road, London NW1 7BY, UK. Electronic address: david.collingridge@lancet.com.
² Kings Health Partners, King's College, Guy's Hospital Campus, London SE1 9RT, UK.

No abstract available

Comment on

Does comparative effectiveness research promote rationing of cancer care?
Peppercorn J, Zafar SY, Houck K, Ubel P, Meropol NJ. Peppercorn J, et al. Lancet Oncol. 2014 Mar;15(3):e132-8. doi: 10.1016/S1470-2045(13)70597-7. Epub 2014 Feb 14. Lancet Oncol. 2014. PMID: 24534292
Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries.
Chalkidou K, Marquez P, Dhillon PK, Teerawattananon Y, Anothaisintawee T, Gadelha CA, Sullivan R. Chalkidou K, et al. Lancet Oncol. 2014 Mar;15(3):e119-31. doi: 10.1016/S1470-2045(13)70547-3. Epub 2014 Feb 14. Lancet Oncol. 2014. PMID: 24534293
Delivering maximum clinical benefit at an affordable price: engaging stakeholders in cancer care.
Kelly RJ, Smith TJ. Kelly RJ, et al. Lancet Oncol. 2014 Mar;15(3):e112-8. doi: 10.1016/S1470-2045(13)70578-3. Epub 2014 Feb 14. Lancet Oncol. 2014. PMID: 24534294